{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T20:56:34Z","timestamp":1769547394384,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s11938-007-0049-4","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T14:57:17Z","timestamp":1205506637000},"page":"495-503","source":"Crossref","is-referenced-by-count":36,"title":["The multiple facets of ABCB4 (MDR3) deficiency"],"prefix":"10.1007","volume":"10","author":[{"given":"Shikha S.","family":"Sundaram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,15]]},"reference":[{"key":"49_CR1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/hep.510280234","volume":"28","author":"A.J. Smith","year":"1998","unstructured":"Smith AJ, de Vree JM, Ottenhoff R, et al.: Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in Mdr2 (-\/-) mice. Hepatology 1998, 28:530\u2013536.","journal-title":"Hepatology"},{"key":"49_CR2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0092-8674(94)90446-4","volume":"77","author":"S. Ruetz","year":"1994","unstructured":"Ruetz S, Gros P: Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 1994, 77:1071\u20131081.","journal-title":"Cell"},{"key":"49_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1096\/fasebj.11.1.9034162","volume":"11","author":"R.P. Elferink","year":"1997","unstructured":"Elferink RP, Tytgat GN, Groen AK: Hepatic canalicular membrane 1: the role of mdr2 P-glycoprotein in hepatobiliary lipid transport. FASEB J 1997, 11:19\u201328.","journal-title":"FASEB J"},{"key":"49_CR4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-2001-19033","volume":"21","author":"E. Jacquemin","year":"2001","unstructured":"Jacquemin E: Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases. Semin Liver Dis 2001, 21:551\u2013562.","journal-title":"Semin Liver Dis"},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1172\/JCI117658","volume":"95","author":"R.P. Oude Elferink","year":"1995","unstructured":"Oude Elferink RP, Ottenhoff R, van Wijland M, et al.: Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. J Clin Invest 1995, 95:31\u201338.","journal-title":"J Clin Invest"},{"key":"49_CR6","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"M. Trauner","year":"2003","unstructured":"Trauner M, Boyer JL: Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 2003, 83:633\u2013671.","journal-title":"Physiol Rev"},{"key":"49_CR7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","volume":"75","author":"J.J. Smit","year":"1993","unstructured":"Smit JJ, Schinkel AH, Oude Elferink RP, et al.: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 1993, 75:451\u2013462.","journal-title":"Cell"},{"key":"49_CR8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","volume":"453","author":"R.P. Oude Elferink","year":"2007","unstructured":"Oude Elferink RP, Paulusma CC: Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch 2007, 453:601\u2013610.","journal-title":"Pflugers Arch"},{"key":"49_CR9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","volume":"27","author":"M. Trauner","year":"2007","unstructured":"Trauner M, Fickert P, Wagner M: MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis 2007, 27:77\u201398.","journal-title":"Semin Liver Dis"},{"key":"49_CR10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0022-2275(20)42016-4","volume":"37","author":"R.P. Oude Elferink","year":"1996","unstructured":"Oude Elferink RP, Ottenhoff R, van Wijland M, et al.: Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. J Lipid Res 1996, 37:1065\u20131075.","journal-title":"J Lipid Res"},{"key":"49_CR11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/jhep.2000.9605","volume":"32","author":"S. Gupta","year":"2000","unstructured":"Gupta S, Todd Stravitz R, Pandak WM, et al.: Regulation of multidrug resistance 2 P-glycoprotein expression by bile salts in rats and in primary cultures of rat hepatocytes. Hepatology 2000, 32:341\u2013347.","journal-title":"Hepatology"},{"key":"49_CR12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/bj3210389","volume":"321","author":"C.M. Frijters","year":"1997","unstructured":"Frijters CM, Ottenhoff R, van Wijland MJ, et al.: Regulation of mdr2 P-glycoprotein expression by bile salts. Biochem J 1997, 321:389\u2013395.","journal-title":"Biochem J"},{"key":"49_CR13","doi-asserted-by":"crossref","first-page":"51085","DOI":"10.1074\/jbc.M308321200","volume":"278","author":"L. Huang","year":"2003","unstructured":"Huang L, Zhao A, Lew JL, et al.: Farnesoid X receptor activates transcription of the phospholipid pump MDR3. J Biol Chem 2003, 278:51085\u201351090.","journal-title":"J Biol Chem"},{"key":"49_CR14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1042\/bj3140781","volume":"314","author":"J. Chianale","year":"1996","unstructured":"Chianale J, Vollrath V, Wielandt AM, et al.: Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse. Biochem J 1996, 314:781\u2013786.","journal-title":"Biochem J"},{"key":"49_CR15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/bj20020981","volume":"369","author":"T. Kok","year":"2003","unstructured":"Kok T, Bloks VW, Wolters H, et al.: Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem J 2003, 369:539\u2013547.","journal-title":"Biochem J"},{"key":"49_CR16","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00228-003-0704-1","volume":"59","author":"N. Roglans","year":"2004","unstructured":"Roglans N, Vazquez-Carrera M, Alegret M, et al.: Fibrates modify the expression of key factors involved in bile-acid synthesis and biliary-lipid secretion in gallstone patients. Eur J Clin Pharmacol 2004, 59:855\u2013861.","journal-title":"Eur J Clin Pharmacol"},{"key":"49_CR17","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1194\/jlr.M400132-JLR200","volume":"45","author":"J. Shoda","year":"2004","unstructured":"Shoda J, Inada Y, Tsuji A, et al.: Benzfibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARalpha-mediated redistribution of ABCB4. J Lipid Res 2004, 45:1813\u20131825.","journal-title":"J Lipid Res"},{"key":"49_CR18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","volume":"120","author":"E. Jacquemin","year":"2001","unstructured":"Jacquemin E, De Vree JM, Cresteil D, et al.: The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001, 120:1448\u20131458.","journal-title":"Gastroenterology"},{"key":"49_CR19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.510230435","volume":"23","author":"J.F. Deleuze","year":"1996","unstructured":"Deleuze JF, Jacquemin E, Dubuisson C, et al.: Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology 1996, 23:904\u2013908.","journal-title":"Hepatology"},{"key":"49_CR20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.510250303","volume":"25","author":"E. Jacquemin","year":"1997","unstructured":"Jacquemin E, Hermans D, Myara A, et al.: Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology 1997, 25:519\u2013523.","journal-title":"Hepatology"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/gast.1996.v111.pm8698195","volume":"111","author":"C.M. Nieuwkerk Van","year":"1996","unstructured":"Van Nieuwkerk CM, Elferink RP, Groen AK, et al.: Effects of ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996, 111:165\u2013171.","journal-title":"Gastroenterology"},{"key":"49_CR22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.95.1.282","volume":"95","author":"J.M. Vree de","year":"1998","unstructured":"de Vree JM, Jacquemin E, Sturm E, et al.: Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 1998, 95:282\u2013287.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"49_CR23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1089-3261(05)70139-2","volume":"4","author":"E. Jacquemin","year":"2000","unstructured":"Jacquemin E: Progressive familial intrahepatic cholestasis. Genetic basis and treatment. Clin Liver Dis 2000, 4:753\u2013763.","journal-title":"Clin Liver Dis"},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.transproceed.2003.10.047","volume":"35","author":"A. Bassas","year":"2003","unstructured":"Bassas A, Chehab M, Hebby H, et al.: Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis. Transplant Proc 2003, 35:3003\u20133005.","journal-title":"Transplant Proc"},{"key":"49_CR25","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1053\/gast.2000.20222","volume":"119","author":"J.M. Vree De","year":"2000","unstructured":"De Vree JM, Ottenhoff R, Bosma PJ, et al.: Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 2000, 119:1720\u20131730.","journal-title":"Gastroenterology"},{"key":"49_CR26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MPG.0b013e318036a569","volume":"44","author":"C. Jung","year":"2007","unstructured":"Jung C, Driancourt C, Baussan C, et al.: Prenatal molecular diagnosis of inherited cholestatic diseases. J Pediatr Gastroenterol Nutr 2007, 44:453\u2013458.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"49_CR27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.20022","volume":"39","author":"F. Lammert","year":"2004","unstructured":"Lammert F, Wang DQ, Hillebrandt S, et al.: Spontaneous cholecysto-and hepatolithiasis in Mdr2-\/-mice: a model for low phospholipid-associated cholelithiasis. Hepatology 2004, 39:117\u2013128.","journal-title":"Hepatology"},{"key":"49_CR28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/gast.2001.23947","volume":"120","author":"O. Rosmorduc","year":"2001","unstructured":"Rosmorduc O, Hermelin B, Poupon R: MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001, 120:1459\u20131467.","journal-title":"Gastroenterology"},{"key":"49_CR29","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0016-5085(03)00898-9","volume":"125","author":"O. Rosmorduc","year":"2003","unstructured":"Rosmorduc O, Hermelin B, Boelle PY, et al.: ABCB4 gene mutation-associated cholelithiasis in adults. Gastroenterology 2003, 125:452\u2013459.","journal-title":"Gastroenterology"},{"key":"49_CR30","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0168-8278(00)80139-7","volume":"33","author":"F. Lammert","year":"2000","unstructured":"Lammert F, Marschall HU, Glantz A, Matern S: Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000, 33:1012\u20131021.","journal-title":"J Hepatol"},{"key":"49_CR31","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/gast.2003.50144","volume":"124","author":"J.F. Lucena","year":"2003","unstructured":"Lucena JF, Herrero JI, Quiroga J, et al.: A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003, 124:1037\u20131042.","journal-title":"Gastroenterology"},{"key":"49_CR32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.hepres.2004.03.002","volume":"29","author":"M. Kano","year":"2004","unstructured":"Kano M, Shoda J, Sumazaki R, et al.: Mutations identified in the human multidrug resistance P-glycoprotein 3 (ABCB4) gene in patients with primary hepatolithiasis. Hepatol Res 2004, 29:160\u2013166.","journal-title":"Hepatol Res"},{"key":"49_CR33","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/jhep.2001.23936","volume":"33","author":"J. Shoda","year":"2001","unstructured":"Shoda J, Oda K, Suzuki H, et al.: Etiologic significance of defects in cholesterol, phospholipid, and bile acid metabolism in the liver of patients with intrahepatic calculi. Hepatology 2001, 33:1194\u20131205.","journal-title":"Hepatology"},{"key":"49_CR34","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2741\/1826","volume":"11","author":"J. Shoda","year":"2006","unstructured":"Shoda J, Inada Y, Osuga T: Molecular pathogenesis of hepatolithiasis\u2014a type of low phospholipid-associated cholelithiasis. Front Biosci 2006, 11:669\u2013675.","journal-title":"Front Biosci"},{"key":"49_CR35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.510300108","volume":"30","author":"S. Tomida","year":"1999","unstructured":"Tomida S, Abei M, Yamaguchi T, et al.: Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis. Hepatology 1999, 30:6\u201313.","journal-title":"Hepatology"},{"key":"49_CR36","first-page":"163","volume":"5","author":"F. Lammert","year":"2005","unstructured":"Lammert F, Matern S: The genetic background of cholesterol gallstone formation: an inventory of human lithogenic genes. Curr Drug Targets 2005, 5:163\u2013170.","journal-title":"Curr Drug Targets"},{"key":"49_CR37","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1111\/j.1572-0241.2000.03220.x","volume":"95","author":"T. Kurihara","year":"2000","unstructured":"Kurihara T, Niimi A, Maeda A, et al.: Benzfibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid. Am J Gastroenterol 2000, 95:2990\u20132992.","journal-title":"Am J Gastroenterol"},{"key":"49_CR38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1089-3261(03)00131-4","volume":"8","author":"C.A. Riely","year":"2004","unstructured":"Riely CA, Bacq Y: Intrahepatic cholestasis of pregnancy. Clin Liver Dis 2004, 8:167\u2013176.","journal-title":"Clin Liver Dis"},{"key":"49_CR39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(05)77221-4","volume":"353","author":"E. Jacquemin","year":"1999","unstructured":"Jacquemin E, Cresteil D, Manouvrier S, et al.: Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999, 353:210\u2013211.","journal-title":"Lancet"},{"key":"49_CR40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/gut.2006.092742","volume":"56","author":"H.E. Wasmuth","year":"2007","unstructured":"Wasmuth HE, Glantz A, Keppeler H, et al.: Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene. Gut 2007, 56:265\u2013270.","journal-title":"Gut"},{"key":"49_CR41","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1365-2036.2006.02869.x","volume":"23","author":"A. Floreani","year":"2006","unstructured":"Floreani A, Carderi I, Paternoster D, et al.: Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations. Aliment Pharmacol Ther 2006, 23:1649\u20131653.","journal-title":"Aliment Pharmacol Ther"},{"key":"49_CR42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00008571-200402000-00003","volume":"14","author":"C. Pauli-Magnus","year":"2004","unstructured":"Pauli-Magnus C, Lang T, Meier Y, et al.: Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004, 14:91\u2013102.","journal-title":"Pharmacogenetics"},{"key":"49_CR43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.21500","volume":"45","author":"G. Schneider","year":"2007","unstructured":"Schneider G, Paus TC, Kullak-Ublick GA, et al.: Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy. Hepatology 2007, 45:150\u2013158.","journal-title":"Hepatology"},{"key":"49_CR44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11938-003-0013-x","volume":"6","author":"F. Lammert","year":"2003","unstructured":"Lammert F, Marschall HU, Matern S: Intrahepatic cholestasis of pregnancy. Curr Treat Options Gastroenterol 2003, 6:123\u2013132.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"49_CR45","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0168-8278(00)80214-7","volume":"32","author":"H. Reyes","year":"2000","unstructured":"Reyes H, Baez ME, Gonzalez MC, et al.: Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 2000, 32:542\u2013549.","journal-title":"J Hepatol"},{"key":"49_CR46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1055\/s-2007-1007357","volume":"13","author":"H. Reyes","year":"1993","unstructured":"Reyes H, Simon FR: Intrahepatic cholestasis of pregnancy: an estrogen-related disease. Semin Liver Dis 1993, 13:289\u2013301.","journal-title":"Semin Liver Dis"},{"key":"49_CR47","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0016-5085(00)70224-1","volume":"118","author":"B. Stieger","year":"2000","unstructured":"Stieger B, Fattinger K, Madon J, et al.: Drug-and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (BSEP) of rat liver. Gastroenterology 2000, 118:422\u2013430.","journal-title":"Gastroenterology"},{"key":"49_CR48","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/07853890009011758","volume":"32","author":"H. Reyes","year":"2000","unstructured":"Reyes H, Sjovall J: Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy. Ann Med 2000, 32:94\u2013106.","journal-title":"Ann Med"},{"key":"49_CR49","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0016-5085(87)90922-X","volume":"93","author":"H. Reyes","year":"1987","unstructured":"Reyes H, Radrigan ME, Gonzalez MC, et al.: Steatorrhea in patients with intrahepatic cholestasis of pregnancy. Gastroenterology 1987, 93:584\u2013590.","journal-title":"Gastroenterology"},{"key":"49_CR50","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0002-9378(94)70304-3","volume":"170","author":"A.J. Rioseco","year":"1994","unstructured":"Rioseco AJ, Ivankovic MB, Manzur A, et al.: Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994, 170:890\u2013895.","journal-title":"Am J Obstet Gynecol"},{"key":"49_CR51","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.20952","volume":"42","author":"A. Glantz","year":"2005","unstructured":"Glantz A, Marschall HU, Lammert F, Mattsson LA: Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid. Hepatology 2005, 42:1399\u20131405.","journal-title":"Hepatology"},{"key":"49_CR52","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/jhep.2002.36088","volume":"36","author":"G. Paumgartner","year":"2002","unstructured":"Paumgartner G, Beuers U: Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002, 36:525\u2013531.","journal-title":"Hepatology"},{"key":"49_CR53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0020-7292(95)02528-6","volume":"52","author":"A. Diaferia","year":"1996","unstructured":"Diaferia A, Nicastri PL, Tartagni M, et al.: Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 1996, 52:133\u2013140.","journal-title":"Int J Gynaecol Obstet"},{"key":"49_CR54","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0168-8278(97)80146-8","volume":"27","author":"J. Palma","year":"1997","unstructured":"Palma J, Reyes H, Ribalta J, et al.: Ursodeoxycholic acid in the treatment of cholestasis of pregnancy: a randomized, double-blind study controlled with placebo. J Hepatol 1997, 27:1022\u20131028.","journal-title":"J Hepatol"},{"key":"49_CR55","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1478-3231.2004.0996.x","volume":"25","author":"R. Zapata","year":"2005","unstructured":"Zapata R, Sandoval L, Palma J, et al.: Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy. A 12-year experience. Liver Int 2005, 25:548\u2013554.","journal-title":"Liver Int"},{"key":"49_CR56","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/jhep.2001.22647","volume":"33","author":"G. Mazzella","year":"2001","unstructured":"Mazzella G, Rizzo N, Azzaroli F, et al.: Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers. Hepatology 2001, 33:504\u2013508.","journal-title":"Hepatology"},{"key":"49_CR57","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1471-0528.1998.tb09976.x","volume":"105","author":"P.L. Nicastri","year":"1998","unstructured":"Nicastri PL, Diaferia A, Tartagni M, et al.: A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1998, 105:1205\u20131207.","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl2","key":"49_CR58","first-page":"122","volume":"37","author":"M. Frezza","year":"1990","unstructured":"Frezza M, Centini G, Cammareri G, et al.: S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial. Hepatogastroenterology 1990, 37(Suppl 2):122\u2013125.","journal-title":"Hepatogastroenterology"},{"key":"49_CR59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1515\/JPM.2006.077","volume":"34","author":"T. Binder","year":"2006","unstructured":"Binder T, Salaj P, Zima T, Vitek L: Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. J Perinat Med 2006, 34:383\u2013391.","journal-title":"J Perinat Med"},{"key":"49_CR60","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/hep.1840150612","volume":"15","author":"J. Palma","year":"1992","unstructured":"Palma J, Reyes H, Ribalta J, et al.: Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992, 15:1043\u20131047.","journal-title":"Hepatology"},{"key":"49_CR61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1471-0528.2003.00029.x","volume":"111","author":"N. Roncaglia","year":"2004","unstructured":"Roncaglia N, Locatelli A, Arreghini A, et al.: A randomised controlled trial of ursodeoxycholic acid and S-adenosyll-methionine in the treatment of gestational cholestasis. BJOG 2004, 111:17\u201321.","journal-title":"BJOG"},{"key":"49_CR62","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1471-0528.1992.tb14465.x","volume":"99","author":"M.L. Hirvioja","year":"1992","unstructured":"Hirvioja ML, Tuimala R, Vuori J: The treatment of intrahepatic cholestasis of pregnancy by dexamethasone. Br J Obstet Gynaecol 1992, 99:109\u2013111.","journal-title":"Br J Obstet Gynaecol"},{"key":"49_CR63","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1053\/j.gastro.2005.06.019","volume":"129","author":"J. Kondrackiene","year":"2005","unstructured":"Kondrackiene J, Beuers U, Kupcinskas L: Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy. Gastroenterology 2005, 129:894\u2013901.","journal-title":"Gastroenterology"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0049-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-007-0049-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-007-0049-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,5]],"date-time":"2021-09-05T23:23:34Z","timestamp":1630884214000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-007-0049-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1007\/s11938-007-0049-4","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}